Clinical Trial Update: Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxel [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating cetirizine as a replacement for diphenhydramine to prevent reactions related to paclitaxel in cancer patients; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cervical Cancer
• Endometrial Cancer
• Esophageal Cancer
• Head and Neck Cancer
• Lung Cancer
• Ovarian Cancer

Drugs mentioned

• Cetirizine (cetirizine)
• Diphenhydramine (diphenhydramine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Ciusss de L'Est de l'Île de Montréal | Conditions: Breast Cancer, Lung Cancer | Phase 3 | Status: COMPLETED